Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

VAXX

Vaxxinity (VAXX)

Vaxxinity Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VAXX
일자시간출처헤드라인심볼기업
2024/05/1005:24Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:VAXXVaxxinity Inc
2024/05/1005:09Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:VAXXVaxxinity Inc
2024/04/2007:53GlobeNewswire Inc.Vaxxinity Issues Shareholder LetterNASDAQ:VAXXVaxxinity Inc
2024/04/2005:27GlobeNewswire Inc.Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common StockNASDAQ:VAXXVaxxinity Inc
2024/03/2822:23GlobeNewswire Inc.Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual MeetingNASDAQ:VAXXVaxxinity Inc
2024/03/2805:41GlobeNewswire Inc.Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:VAXXVaxxinity Inc
2024/03/0800:32GlobeNewswire Inc.Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024NASDAQ:VAXXVaxxinity Inc
2024/02/1606:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
2024/02/1522:00GlobeNewswire Inc.Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data PublishedNASDAQ:VAXXVaxxinity Inc
2024/02/1322:00GlobeNewswire Inc.Vaxxinity to Present Clinical and Preclinical Pipeline Data at AD/PD 2024NASDAQ:VAXXVaxxinity Inc
2024/02/1307:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VAXXVaxxinity Inc
2024/02/1307:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VAXXVaxxinity Inc
2024/01/3022:00GlobeNewswire Inc.Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of FloridaNASDAQ:VAXXVaxxinity Inc
2024/01/1822:00GlobeNewswire Inc.Vaxxinity Announces Collaboration on Space Medicine Research with University of Central FloridaNASDAQ:VAXXVaxxinity Inc
2024/01/0322:00GlobeNewswire Inc.Vaxxinity to Present at the 2024 J.P. Morgan Healthcare ConferenceNASDAQ:VAXXVaxxinity Inc
2023/12/0200:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
2023/12/0107:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/12/0106:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/11/3007:13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/11/3007:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/11/2206:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/11/2206:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/11/1408:50GlobeNewswire Inc.Vaxxinity to Present at Upcoming November Medical and Investor ConferencesNASDAQ:VAXXVaxxinity Inc
2023/11/0822:30GlobeNewswire Inc.Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VAXXVaxxinity Inc
2023/11/0821:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VAXXVaxxinity Inc
2023/11/0405:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VAXXVaxxinity Inc
2023/10/0505:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/10/0505:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
2023/09/2905:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VAXXVaxxinity Inc
2023/09/2305:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VAXXVaxxinity Inc
 검색 관련기사 보기:NASDAQ:VAXX